SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending amid speculation surrounding a potential US-China trade deal as Trump and Xi meet, with many anticipating a market pump regardless of the actual outcome. Some community members are concerned about overvaluation and the impact of potential AI-driven unemployment, while others are focused on technical levels and potential market reactions to earnings reports and Fed policy. Additionally, there's some chatter about potential nuclear weapons testing.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as investors digest the latest Fed commentary and anticipate earnings reports from major tech companies like Meta and Microsoft. Community sentiment appears bullish despite some mixed signals, with discussions focused on AI's impact and the potential for a Trump-Xi meeting to influence market direction. Some traders express concern about stretched valuations and poor market breadth, while others remain optimistic about a year-end rally.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir ($PLTR) is trending as it approaches its all-time high, fueled by enthusiasm around AI and potential partnerships, with some eyeing the $200 mark and a possible stock split. The community is debating whether the valuation is justified, while noting the strong momentum and short squeezes. Some are comparing it to other high-growth tech stocks.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Despite strong revenue growth, Meta Platforms is trending due to concerns about increased spending on AI and infrastructure, as well as a one-time tax charge impacting earnings. The community is debating whether the dip represents a buying opportunity or signals deeper issues with the company's investment strategy. Discussions also involve comparing Meta's situation and valuation to other tech giants like Google and Microsoft.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin ($BROKE) is trending as community members express bullish sentiment and promote the coin's strong community and active developer. Talk centers around a 3000 watcher burn goal and the potential for new all-time highs, with many highlighting the project's commitment to its roadmap. The coin is closely associated with the $WAGMI (We're All Gonna Make It) meme and the Solana blockchain.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors discuss the implications of increased AI spending and its impact on earnings, with some expressing concern over potential profit forecasts. Community members are weighing the significance of OpenAI's potential IPO and Microsoft's stake. Overall sentiment appears mixed as the market digests recent earnings reports.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as it surpasses a $5 trillion market cap, driven by strong AI chip demand and optimism surrounding potential outcomes from the Trump-Xi meeting, particularly regarding Blackwell chip exports to China. The community is discussing whether this valuation is justified, with debates around profit margins, market competition, and the sustainability of AI-related growth, while anticipating further rallies.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle's stock is trending downwards amid concerns about declining traffic and a lowered sales forecast, despite beating EPS estimates. The community is debating whether the stock is now undervalued, while also discussing the impact of pricing and portion sizes on customer loyalty. Some traders are eyeing a potential bounce, while others express concerns about the company's leadership and long-term prospects.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet's shares are trending following a record quarter fueled by growth in its cloud and AI divisions, which has prompted increased capital expenditure plans; the community is buzzing about the company's AI strategy and potential for continued growth, with some hailing it as a portfolio-saving stock. The positive sentiment is further amplified by the fact that Google's search revenues remain strong despite the rise of ChatGPT, reinforcing the company's dominance in the tech landscape.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending as investors analyze its potential following strong Q3 earnings, with revenue exceeding expectations and AI advancements driving growth. The community is focused on the company's increased capital expenditures and the potential impact of AI on its search revenues, considering whether GOOGL can reach new price targets. Some analysts see significant upside, citing the strength of Google's ad and AI strategy relative to peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Does Monopar Therapeutics (MNPR) Have the Potential to Rally 42.46% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 42.5% in Monopar Therapeutics (MNPR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's  What You Should Know

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics PR Newswire NORTH CHICAGO, Ill., Jan...

Up 1,000% in 2024, Wall Street Believes This Growth Stock Can Still Skyrocket

This biotech stock is a promising buy, but it does come with risks.

Monopar Therapeutics Inc. ($MNPR)Shares of Monopar skyrocketed over 350% by mid-day Thursday after the Wilmette, Illinois-based micro-cap biotech announced an agreement with AstraZeneca plc’s ($AZN) Alexion rare disease subsidiary to exclusively in-license the latter’s ALXN-1840.&nbsp;The drug candidate is a Phase 3 asset and is being investigated for treating Wilson disease, a&nbsp; rare and progressive genetic condition in which the body’s pathway for removing excess copper is compromised.&nbsp;The agreement calls upon Monopar paying an upfront cash payment and giving AstraZeneca an equity stake. The smaller biotech is also required to make regulatory and sales milestones-based future payments and royalties on future net sales.<figure class="image"><a href="https://stocktwits.com/symbol/MNPR"><img style="aspect-ratio:628/148;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/mnpr_sentiment_224afae297.png" alt="mnpr-sentiment.png" width="628" height="148"></a><figcaption>MNPR sentiment and message volume October 24, 2024, as of 2 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>Monopar said it will be responsible for all future development and commercialization activities.&nbsp;Energy Vault Holdings, Inc. ($NRGV)Retail sentiment toward Westlake Village, California-based Energy Vault contrasted the stock move on Thursday. The stock was down over 7% by mid-Thursday despite the lack of any major catalyst.&nbsp;On Monday, Energy Vault, a sustainable, grid-scale energy storage solutions provider, announced an agreement with Australian energy developer Enervest Group for the deployment of a 1,000 MWh battery energy storage in New South Wales, Australia.&nbsp;The stock jumped 25% over the next two sessions before pulling back.<figure class="image"><a href="https://stocktwits.com/symbol/NRGV"><img style="aspect-ratio:638/147;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/nrgv_sentiment_ad5ef0470a.png" alt="nrgv-sentiment.png" width="638" height="147"></a><figcaption>&nbsp;NRGV sentiment and message volume October 24, 2024, as of 2 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>On Stocktwits, retail sentiment was ‘extremely bullish’ (97/100) compared to the ‘neutral’ sentiment that prevailed on Wednesday.FREYR Battery, Inc. ($FREY)Luxembourg-headquartered FREYR, which manufactures lithium-ion batteries in its Norwegian facilities, has also found traction with retail investors.&nbsp;The green-energy company’s stock may have received a lift from the news that the European Union Innovation Fund has agreed to award 122 million-euro ($132.05 million) to develop its potential joint venture ‘Cathode Active Material’ manufacturing project in Vaasa, Finland.<figure class="image"><a href="https://stocktwits.com/symbol/FREY"><img style="aspect-ratio:637/145;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/frey_sentiment_6c4bdbd8f7.png" alt="frey-sentiment.png" width="637" height="145"></a><figcaption>FREY sentiment and message volume October 24, 2024, as of 2 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>The retail mood is exceedingly exuberant, with the sentiment score on Stocktwits at 97/100.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/quantumscape-stock-jumps-on-earnings-call-updates/cJ21uofR7Z">QuantumScape Stock Bounces Back After Earnings Call Boost, Tesla Tailwinds: Retail Turns Optimistic</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

These 3 stocks have generated the most bullish sentiment among retailers Thursday afternoon.

Monopar Therapeutics, Energy Vault Holdings, FREYR Battery: 3 Stocks Retailers Are Most Bullish Thursday Afternoon

A micro-cap, clinical-stage biotech and two battery manufacturers elicited the most bullish reaction from retail traders.

Equity

A micro-cap, clinical-stage biotech and two battery manufacturers elicited the most bullish reaction from retail traders.


Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder

Monopar secures an exclusive license from AstraZeneca's Alexion for ALXN-1840, aiming to advance treatment for Wilson's disease, a rare genetic disorder.
read more...

Shares of Monopar Therapeutics, Inc. (<a class="mention" data-mention="$MNPR" data-symbol-id="MNPR" href="https://stocktwits.com/symbol/MNPR" target="_blank">$MNPR</a>) soared over 500% on Thursday following a major licensing agreement with AstraZeneca (<a class="mention" data-mention="$AZN" data-symbol-id="AZN" href="https://stocktwits.com/symbol/AZN" target="_blank">$AZN</a>) unit Alexion.&nbsp;The stock hit its highest levels since March 2021 and became the top gainer across U.S. exchanges, with retail sentiment surging into ‘extremely bullish’ territory.Monopar secured the rights to ALXN-1840, an oral treatment for Wilson’s disease, a rare genetic disorder that leads to toxic copper build-up in organs.&nbsp;The company will be responsible for all future global development and commercialization activities.In exchange, Monopar will pay an upfront sum in cash and equity, along with future royalties and milestone payments.&nbsp;Under Alexion’s prior development, ALXN-1840 had already met its primary endpoint in a Phase 3 clinical trial.On Stocktwits, retail sentiment for MNPR jumped to ‘extremely bullish’ (97/100), the highest score this year, driven by a surge in message volume as investors reacted to the breakthrough deal.&nbsp;<stembedurl>https://stocktwits.com/Krystian_v/message/589991504</stembedurl><stembedurl>https://stocktwits.com/Mosconi/message/589994892</stembedurl>Monpar stated that its MD, Co-Founder, and CEO, Chandler Robinson, previously conducted laboratory research on tetrathiomolybdate, published his findings in Science, and helped launch the company behind what became ALXN-1840. The focus was on Wilson disease.Wilson’s disease affects around 1 in 30,000 people in the U.S., causing excess copper to accumulate in the liver, brain, and other organs.&nbsp;The disease can lead to liver failure, neurological symptoms, and psychiatric issues, with many cases suffering irreversible damage.MNPR stock has now surged over 1,500% year-to-date.For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next: <a href="https://stocktwits.com/news-articles/markets/equity/lilm-stock-crashes-after-insolvency-warning/cJ21sAxR7k">Air-Taxi Firm Lilium’s Stock Nosedives On Insolvency Warning: Retail Mood Darkens</a>

Monopar secured the rights to ALXN-1840, an oral treatment for Wilson’s disease, a rare genetic disorder that leads to toxic copper build-up in organs.

Monopar Stock Skyrockets After Agreement With AstraZeneca's Unit On Wilson's Disease Drug: Retail On Cloud Nine

The company will be responsible for all future global development and commercialization activities.

Monopar Stock Skyrockets After Agreement With AstraZeneca’s Unit On Wilson's Disease Drug: Retail On Cloud Nine

The company will be responsible for all future global development and commercialization activities.


Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today

Monopar Therapeutics shares are trading higher by 108% Thursday morning. The company announced early Phase 1 trial data confirming MNPR-101-Zr's tumor-targeting ability in humans.
read more...

Monopar Therapeutics Inc: Positioned for Growth with Strategic Radiopharmaceutical Pivot and Promising Preclinical Data

JonesTrading analyst Justin Walsh reiterated a Buy rating on Monopar Therapeutics Inc (MNPR Research Report) today and set a price target of $2.0...

Monopar Therapeutics Begins Pioneering MNPR-101-Zr Trial

The latest announcement is out from Monopar Therapeutics Inc (MNPR). Monopar Therapeutics Inc. has reached a pivotal milestone by enrolling the fir...

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.

Monopar Therapeutics Inc

Will Apple (AAPL) beat quarterly earnings? 
 
*Powered by Polymarket

MNPR
Monopar Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MNPR News

MNPRMonopar Therapeutics Inc